Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Calcipotriol with NB-UVB for Vitiligo
NCT06880042Phase 1Enrolling by invitation
- Start
- May 2025
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of tacrolimus and calcipotriol in Vitiligo (2 arms). Primary endpoint: Vitiligo Area Scoring Index improvement at 3 months. Started May 2025; status: enrolling by invitation.
02
Drugs
tacrolimuscalcipotriol
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT06880042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06880042.